Freeline announces supply agreement for haemophilia B program
LONDON, Sept. 23, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical stage, […]
LONDON, Sept. 23, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical stage, […]
CAMBRIDGE, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed […]
BEIJING, Sept. 23, 2020 (GLOBE NEWSWIRE) — 36Kr Holdings Inc. (“36Kr” or the “Company”) (NASDAQ: KRKR), a prominent brand and […]
STOCKHOLM, Sweden and WATERTOWN, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) — Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Selecta […]
BALA CYNWYD, Pa., Sept. 23, 2020 (GLOBE NEWSWIRE) — Leading private markets asset management firm Hamilton Lane (NASDAQ: HLNE) today […]
TORONTO, Sept. 23, 2020 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQB: CHXMF) (“Troilus” or the “Company”) has initiated […]
VANCOUVER, British Columbia, Sept. 23, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]
COLUMBUS, Ohio, Sept. 23, 2020 (GLOBE NEWSWIRE) — Worthington Industries, Inc. (NYSE: WOR) today reported net sales of $702.9 million […]
LA JOLLA, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]
First orally available integrin inhibitor from MInT Platform to enter the clinicMORF-057, inhibitor of α4β7integrin, in development to treat inflammatory […]